OM:VITRBiotechs
Vitrolife (OM:VITR) Trailing SEK5.0b Net Loss Tests Bullish Earnings Recovery Narratives
Vitrolife (OM:VITR) heads into its Q1 2026 update with investors still digesting a sharp swing in its recent numbers, including Q4 2025 revenue of SEK892 million alongside a basic EPS loss of SEK39.23 and a trailing twelve month basic EPS loss of SEK37.01. The company has seen quarterly revenue move between SEK842 million and SEK959 million across the last six reported periods, while basic EPS has ranged from a profit of SEK1.03 in Q4 2024 to a loss per share in Q4 2025. This leaves the top...